Retatrutide
Significant appetite suppression. Researched under SubQ administration, reported half-life ~6 days.
Research use only. Not for human consumption. Not medical advice. 18+.
Researched areas of interest
- Significant appetite suppression
- Strong weight reduction
- Improved glycaemic control
- Triple agonist (GLP-1/GIP/glucagon)
Evidence status
Human trial data
In human trials; not yet approved.
Grades are assigned from the published evidence position, not from how widely a compound is discussed. How grading works.
Handling notes
Prescription medicine. Titrate slowly; GI side effects; manage hydration/diet.
Reconstitution reference
At the common presentation of 30 mg reconstituted with 3 ml of bacteriostatic water, the concentration is 10.0 mg/ml. Draw volumes on a U-100 syringe:
| Reference point | Volume | U-100 units |
|---|---|---|
| 2 mg | 0.2 ml | 20.0 IU |
| 4 mg | 0.4 ml | 40.0 IU |
| 8 mg | 0.8 ml | 80.0 IU |
Arithmetic reference only. These are literature reference points, not a dosing recommendation. Open the full calculator.
Available as research material
| Product | Specification | Per box |
|---|---|---|
| Retatrutide | 5mg × 10 | $93 |
| Retatrutide | 10mg × 10 | $148.5 |
| Retatrutide | 15mg × 10 | $216 |
| Retatrutide | 20mg × 10 | $267 |
| Retatrutide | 30mg × 10 | $364.5 |
| Retatrutide | 40mg × 10 | $447 |
| Retatrutide | 50mg × 10 | $517.5 |
| Retatrutide | 60mg × 10 | $592.5 |
From $93 per box. One price is one box, not one vial. Supplied by an independent laboratory supplier, not by TRAINNORTH:LABS.
Research enquiry via WhatsAppDisclaimer — Research Use Only. Materials referenced on this page are for laboratory research only. They are not intended for human consumption, are not approved as medicines in the United Kingdom unless explicitly stated, and nothing here is medical advice or a dosing protocol. Consult a qualified physician before making any health decision.
← Back to the library